Gastroenterology
Gastroenterology Clinical Research
In the U.S., millions of patients are affected by gastrointestinal disorders, ranging from chronic conditions like IBS and IBD to liver and metabolic diseases. CenExel partners with sponsors to advance innovative GI therapies—delivering high-quality data, patient-focused care, and efficient trial execution across diverse populations.
Studies Conducted
0
+
Trial Participants
0
+
Active Centers
0
Overview
Leading Gastroenterology Clinical Research
Complex gastrointestinal trials require specialized scientific and operational expertise. CenExel’s GI research teams include experienced investigators, coordinators, and patient recruitment specialists—ensuring efficient study execution from first-patient-in to last-patient-out.
Our expertise spans inflammatory bowel diseases, liver disorders, and functional GI conditions. We integrate biomarker-driven strategies, advanced diagnostics, and patient-centric approaches to deliver high-quality outcomes across all trial phases.
Conditions Covered
Gastrointestinal Conditions We Research
Our GI research sites support a broad range of digestive and liver conditions—from common disorders to complex and rare indications.
Irritable Bowel Syndrome (IBS)
Crohn’s Disease
Ulcerative Colitis
Gastroesophageal Reflux Disease (GERD)
Nonalcoholic Steatohepatitis (NASH)
Fatty Liver Disease
Hepatitis B & C
Celiac Disease
Functional Dyspepsia
Constipation & Motility Disorders
Our Approach
Why Sponsors Choose CenExel for Gastroenterology
Our GI expertise goes beyond patient enrollment—we provide scientific insight, operational excellence, and reliable data for regulatory success.
01
GI Specialty Investigators
Experienced investigators with deep expertise in digestive and liver diseases ensure accurate diagnosis, protocol adherence, and high-quality data collection.
02
Biomarker & Endpoint Strategy
We integrate advanced biomarkers, imaging, and endoscopic endpoints to support early decision-making and trial success.
03
Diverse Patient Access
Access to diverse patient populations across multiple regions ensures representative data and improved enrollment performance.
04
Efficient Enrollment
Our in-house recruitment strategies consistently meet and exceed enrollment goals through targeted outreach and patient engagement.
Phase Coverage
Supported Trial Phases
CenExel supports early and late-phase gastroenterology clinical trials—from first-in-human studies to Phase IV post-marketing research.
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Our early phase capabilities include pharmacodynamic biomarker strategies, first-in-human studies, and proof-of-concept trial design — guided by Chief Scientific Officer Dr. Larry Ereshefsky, an internationally recognized KOL in CNS research with over 30 years of early phase expertise.
Let’s Advance Your Next Study
Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.
Explore Our Network
Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.
View More
Therapeutic Area
Neurology
Neurological disorders affect millions worldwide, creating a critical need for innovative research and advanced treatments.
Therapeutic Area
Metabolic
CenExel partners with pharmaceutical and biotechnology sponsors to accelerate obesity, diabetes, and metabolic
Therapeutic Area
Pain
Chronic and acute pain affect millions of individuals worldwide, significantly impacting quality of life.